Cellectis S.A. (CLLS)
NASDAQ: CLLS · Real-Time Price · USD
1.580
-0.070 (-4.24%)
Jul 3, 2025, 1:00 PM - Market closed

Cellectis Market Cap

Cellectis has a market cap or net worth of $119.06 million as of July 3, 2025. Its market cap has decreased by -22.53% in one year.

Market Cap
119.06M
Enterprise Value
84.83M
1-Year Change
-22.53%
Ranking
Category
Stock Price
$1.58

Market Cap Chart

Since March 25, 2015, Cellectis's market cap has decreased from $1.34B to $119.06M, a decrease of -91.14%. That is a compound annual growth rate of -21.00%.

History

DateMarket Cap% Change
Jul 3, 2025114.20M-12.02%
Dec 31, 2024129.80M-24.18%
Dec 29, 2023171.20M78.89%
Dec 30, 202295.70M-74.09%
Dec 31, 2021369.30M-67.88%
Dec 31, 20201.15B58.27%
Dec 31, 2019726.40M2.87%
Dec 31, 2018706.10M-31.45%
Dec 29, 20171.03B72.73%
Dec 30, 2016596.30M-43.80%
Dec 31, 20151.06B-21.04%
View and export this data all the way back to 2015. Sign Up Today.

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding
Full Definition

Related Stocks

Company Market Cap
Eli Lilly and Company 700.84B
Johnson & Johnson 375.37B
AbbVie 334.34B
Novo Nordisk 316.33B
UnitedHealth Group 279.90B
Novartis AG 238.56B
Abbott Laboratories 233.90B
AstraZeneca 216.08B
Market Cap Rankings